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Abstract
Background The policy imperative to engage the public and
patients in research can be seen as part of a wider shift in the
research environment. This study addresses the question: Has there
been a shift in attitudes to Patient and Public Involvement (PPI)
and Public Engagement in Science (PES) amongst researchers?
Methods Attitudes to PPI and PES within a cluster of three
NIHR supported Biomedical Research Centres were explored
through in-depth interviews with 19 researchers.
Results Participants distinguished PPI (as an activity involving
patients and carers in research projects and programmes) from
PES (as an activity that aims to communicate research ﬁndings to
the public, engage the public with broader issues of science policy
or promote a greater understanding of the role of science in soci-
ety). While participants demonstrated a range of attitudes to these
practices, they shared a resistance to sharing power and control of
the research process with the public and patients.
Conclusion While researchers were prepared to engage with the
public and patients and listed the advantages of engagement, the
study revealed few diﬀerences in their underlying attitudes towards
the role of society in science (and science in society) to those
reported in previous studies. To the participants science remains
the preserve of scientists, with patients and the public invited to
‘tinker at the edges’.
Background
Traditionally, the concepts of Patient and
Public Involvement (PPI) in research and Pub-
lic Engagement in Science (PES) have occupied
parallel tracks. PES has a long history as
scientists have sought to educate the public
about science in general and their own scien-
tiﬁc research in particular; restore public trust
in their activities, and obtain and maintain a
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‘license to practice’.1 PPI in health research, as
formally constituted in the UK and other
mainly English speaking countries, is a newer
phenomenon seeking variously to promote par-
ticipatory democracy; increase accountability
of scientiﬁc researchers; and recognize and
draw on experiential knowledge and expertise
of lay users of health care.2 Both might be seen
as part of a broader trend towards reconceptu-
alizing the role of society (i.e. citizens, patients
and the public) in science. Nowotny and col-
leagues3 point to the introduction of systems of
accountability, the steering of research priori-
ties (for example through the EU Framework
programmes) and the emphasis on commercial-
ization as signs of a changing research environ-
ment and a shifting role for science and
scientists.
Some signs of a shift are evident in the aca-
demic literature. For example, Wynne4 explic-
itly calls on scientists and scientiﬁc institutions
to democratize the production of knowledge.
Engagement as a strategy for accountability is
also characterized as a response to a supposed
crisis in trust leading to a so-called democratic
deﬁcit in scientiﬁc research.5 For Weldon,6 a
more accountable science will reverse the
decline of trust in scientists and scientiﬁc
institutions. Nilsen7 cites the WHO Alma Ata
declaration in support of claims that ‘participa-
tion’ in planning, organization, operation and
control of health care, encourages democracy,
accountability and transparency. Boote et al.8
argue that as UK citizens are ﬁnancial
contributors to and therefore part owners of
the NHS they have a right to have a voice in
NHS activities and processes, including
research.
Alongside this academic debate, a set of pol-
icy initiatives have encouraged greater PPI in
health research.9 There has also been a signiﬁ-
cant investment in PES (particularly supported
by science funders such as the UK Wellcome
Trust) and activity by scientists to respond to
public concerns about scientiﬁc issues. While
PES is a more established concept for biomedi-
cal researchers, PPI has a growing currency
particularly given its proﬁle with funding
bodies such as the UK National Institute for
Health Research (NIHR). Furthermore, the
promotion of so-called translational research,
with its focus on investing in research that will
yield applications in clinical practice also
marks a shift towards what Gibbons describes
as ‘Mode 2’ research.10 While Mode 1 is char-
acterized by the autonomy of scientists and the
dominant role of scientiﬁc discovery, Mode 2 is
described as multidisciplinary, socially distrib-
uted and orientated towards application and
use. With this shift comes a renewed emphasis
on both engagement and application.3
There have been few studies exploring the
responses of researchers to these shifts. Those
studies that have focused on researcher
responses11–14 have described researchers seek-
ing to accommodate policy requirements such
as stakeholder engagement and promoting
implementation, but experiencing a ‘pull back’
to Mode 1 from their disciplines and institu-
tions.11 Previous studies have observed the
defensive power of the research commu-
nity.11,12 Ferlie and Wood11 describe the sepa-
ration of research and implementation in one
clinical research team, allowing for high quality
research publications to continue to take prior-
ity. Ward et al. identiﬁed an epistemological
dissonance in which researchers continue to
privilege expertise over experience, attributing
little value to lay knowledge.14 In the Public
Understanding of Science literature, social sci-
entists also discern changes in scientiﬁc activi-
ties and behaviour while ‘the deeper tidal
rhythms of science and its governance remain
resistant’.15 Given the recent policy shifts relat-
ing to PPI and eﬀorts to promote greater
engagement of citizens in the production of sci-
entiﬁc knowledge, this paper investigates
whether there has been a blurring in the dis-
tinction between science and society. In partic-
ular, this study provides an opportunity to
explore the attitudes of academic researchers to
the changing research environment and the
shifting roles of science and scientists, focusing
on researchers located in UK NIHR funded
Biomedical Research Centres (BRCs). We look
in particular at their responses to initiatives
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designed to increase engagement with the pub-
lic and patients and ask: is the shift in policy
and practice around PPI and PES reﬂected in a
shift in attitudes amongst researchers?
Methods
Biomedical Research Centres oﬀer an interest-
ing research setting for a study of PPI and
PES: they are designed to conduct ‘bench to
bedside’ translational research, speeding up the
process of bringing new treatments for patients
from the laboratory to the clinic16 and they
include a range of types of research and
researcher. Furthermore, the NIHR funding
for these ﬂagship initiatives is accompanied by
requirements to adhere to NIHR guidance on
PPI. As part of one BRC, two of the authors
(CM and AB) had been tasked with conducting
research on PPI practice in the BRC and had
observed that basic and some clinician scien-
tists often conﬂated PPI and PES. Given this
observation, this study explored researchers’
attitudes to both PPI and PES within a cluster
of three NIHR supported BRCs, through a
series of in-depth interviews.
Participants were identiﬁed from staﬀ lists
provided by the administrative teams in the
three BRCs. Participants were selected from
one research theme within each centre with the
aim of including both diﬀerent types of
researchers and staﬀ at diﬀerent levels, ranging
from relatively junior staﬀ (research associates
and PhD students) through to professors.
Nineteen researchers were drawn from three
research themes: genetics, mental health and
health services research. The sample included
a mix of basic biomedical scientists, health
service researchers and clinician scientists
(engaged in both research and clinical practice).
Details of the sample are included in Table 1.
Semi-structured interviews were conducted,
using a topic guide covering the following
broad themes: experiences and perceptions of
PPI and PES and beneﬁts and challenges to
PPI and PES. To assess understandings of PPI
and PES practices, the participants were also
asked to carry out a card sorting exercise, in
which they were asked to categorize a set of
cards listing PPI and PES activities most
commonly given in the literature (as deter-
mined through an extensive review of the PPI
and PES literatures) into those they considered
to be typical of PPI and those they considered
to be typical of PES. They were encouraged to
share the reasoning behind their choice during
the exercise, and were free to redesignate activi-
ties to the other category if they so wished, or
to not assign a category if they felt the activity
was not typical of either PPI or PES. In addi-
tion, a card listing commonly given reasons for
PPI and PES derived from the literature was
also used to stimulate discussion. All interviews
were conducted by DB. Interview transcripts
were entered into NVivo9. The initial coding
was generated inductively from close reading
of the transcripts and then grouped into broad
themes that were augmented in the analysis
to take account of emerging interpretations.
Gibbons’ type 1 and type 2 theory was used at
this stage to further interrogate the data.10
Analysis involved a process of constant
comparison, with particular emphasis given to
deviant cases, with the aim of developing inter-
pretation and explanation. This study was
approved by the Biomedical & Health Sciences,
Dentistry, Medicine and Natural & Mathemat-
ical Sciences Research Ethics Committee at
King’s College London.
Findings
While participants had varying levels of experi-
ence of PPI and PES, they were generally clear
on the deﬁnitions of each. When completing
the card sorting exercise, they were consistent
in their categorizations of PPI and PES meth-
ods and activities. Participants made a distinc-
tion between PES and PPI in terms of the level
at which they were undertaken, their purpose
and those who were involved. Broadly speak-
ing, they considered PES to be concerned with
communications with the broader public, often
about science more generally (through, for
example giving talks in schools about the value
and contribution of science to society) and
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improving public understanding of science
through for example media appearances. PPI
was considered to relate to involvement in
individual research projects and programmes.
Participants described a range of activities
including consulting patient groups on ethics
applications, inviting patients to join advisory
groups, and involving patients as researchers.
Despite the label PPI, these activities were typi-
cally associated with patients and carers and not
with the wider public.
You are talking about patients and public and I
think the two things need to be separated (Sue)
The diﬀerences between participants lay in
their underlying attitudes. The attitudes to PPI
expressed in the interviews fell into two main
categories: those who were positive about some
involvement and those who were pragmatically
accommodating PPI. Despite the diﬀerent posi-
tions of the two groups, they shared a resis-
tance to sharing power and control in the
process of knowledge generation. The attitudes
to PES were relatively consistent across the
interviews. Participants were concerned with
promoting a better understanding and accep-
tance of the role of science in society. A single
participant expressed a much more supportive
view of the role of patients and the public. The
following sections discuss these four sets of
attitudes in turn.
Positive attitudes to PPI: ‘You get better
research’
All participants were able to identify a wide
range of potential outcomes for activities
designed to involve patients and the public
including promoting public awareness of
research, improving research recruitment and
increasing the relevance of research. However,
some participants talked more positively of the
importance of PPI and this group perceived
of some beneﬁts to engaging with patients
and the public. In particular, health services
researchers referred to the potential to improve
the quality of research tools, questions, pro-
cesses and outcomes.
I think it’s really, really, really important, and the
research I think that’s important, because you get
better research, you get better questions, you get
Table 1 Interview participants
Pseudonym Post Research area
Janet Professor Health Services Researcher – Innovations
Allan Professor Biomedical Scientist (Clinician Scientist) – Mental Health
Roger Professor Biomedical Scientist – Genetics
Trevor Professor Biomedical Scientist – Mental Health
Peter Reader Biomedical Scientist – Genetics
Raj Senior Lecturer Health Service Researcher (Clinician Scientist) – Mental Health
Sue Research Fellow Health Service Researcher – Innovations
Anna Research Fellow Health Service Researcher – Innovations
Sam Research Associate Health Service Researcher – Innovations
Philip Research Associate Health Service Researcher – Innovations
Jackie Research Associate/ PhD student Health Service Researcher – Innovations
Ewan Post-doctoral Researcher Biomedical Scientist – Genetics
Tanya Post-doctoral Researcher Biomedical Scientist – Genetics
James Post-doctoral Researcher Biomedical Scientist – Genetics
Jack Post-doctoral Researcher Health Service Researcher – Mental Health
Zoe PhD student Biomedical Scientist – Genetics
Tom PhD student Health Service Researcher – Mental Health
Jude PhD student Health Service Researcher – Mental Health
Shaun Research Assistant Health Service Researcher – Mental Health
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challenged, you design your studies diﬀerently,
you choose diﬀerent outcome measures. . .’
(Janet)
Another participant supported this view,
describing the potential for the views of
patients and the public to be ‘like dynamite’ in
changing thinking and practice. Those who
identiﬁed beneﬁts often spoke of their own
personal positive experiences. For example, one
professor experienced in PES commented on
his more recent PPI activities:
[We] have become very aware of the need to
involve users and participants and we’ve sought
their advice and help to design better studies, to
help with the recruitment, to help understand the
experience of the subject of research, so we’ve
been involving them all the way along. Prior to
that, I didn’t give it suﬃcient attention in my
research, so it’s something I’ve, sort of, become
more aware of in recent years. I mean, in terms
of public engagement, I have been involved with
some research that’s had quite a high proﬁle and
I have been involved with press releases and writ-
ing articles for the sort of lay press as well as the
sort of scientiﬁc press. So that’s been of interest
and I think I kind of understand how to commu-
nicate with the general public. Well, I’ve been
better since having had to do it. (Trevor)
Some participants referred to the positive
impact of being exposed to new perspectives
and patient experiences. Janet felt that involv-
ing patients in her research had led to better
research questions, the selection of more
appropriate designs and outcome measures and
had brought an element of challenge to the
research process. Sam described how involving
parents in a study of support for physically dis-
abled children in mainstream schools made a
diﬀerence in terms of implementation as the
parents were keen to avoid the ﬁndings gather-
ing dust in a library. This motivated the
researchers to secure additional funding to
produce a booklet for schools based on the
ﬁndings.
Yet, they also shared a number of challenges
based on their experience, including diﬃculties
recruiting service users to be ‘involved’, and
the need for research training for patients and
the public. Two participants commented on the
signiﬁcant amount of work that had to be
performed before the service users could get
more actively involved in research (including
recruitment, obtaining honorary contracts etc.).
In one case, recruitment to the study had
ﬁnished by the time the service user was in
post. Recruitment was the aspect of the project
where the researcher had planned for the
service user to contribute and for which she
had obtained ethics approval. The researcher
needed to think again about how to include
the service user, how the service user might like
to be involved and whether this change would
have implications for ethics.
I was doing a project where we were trying to
get service users on board, and we had employed
two, from the [local patient group], so we had
gotten them on board, got honorary contracts
for them through [the Trust], and then, of
course, recruitment stopped. So I was kind of left
at a loose end of what to do with them. (Shaun)
In this case, the researcher was left searching
for an ‘appropriate’ task within the project for
the service user researchers.
Pragmatic accommodation of PPI: ‘You just
need the box ticked’
Many interview participants expressed disinter-
est in or active hostility to PPI. Typically, they
described PPI activities as things that ‘had to be
done’. Raj, a senior lecturer described the fund-
ing imperative to demonstrate involvement.
it’s more or less for any funding I think, now-
adays you have to demonstrate some sort of
engagement (Raj)
PPI was described as a bureaucratic activity
designed to fulﬁl policy and funding require-
ments. One participant in this group went as
far as to describe PPI as a scripted activity, in
which patients and the public are encouraged
to play a predetermined, bounded role in the
research process:
With public involvement, it always seems to me
that you’re promising people far more than
you’re ever going to deliver. That you’re encour-
aging them to feel engaged because that’s the
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role that you scripted for them and you want
them to play that part. But really once the study
ends or that part of it ends you don’t really want
much more to do with them. (Sam)
Participants expressed concern about the
skills of patients and the public and their abil-
ity to engage meaningfully in research. One
participant highlighted the diﬃculty in involv-
ing the public in molecular biology at the
bench end of the translational pipeline, com-
pared to clinical trials where the relevance to
patients is more obvious and there may be
scope for more patient involvement. A health
service researcher also referred to the transla-
tional pipeline, expressing the view that health
service research (located closer to the bedside)
provides more opportunities to take on board
and value patient perspectives.
Furthermore, biomedical scientists stressed
the technical nature of their particular areas of
science and argued that specialist knowledge
was required to play an active role in research.
But how could somebody who’s not a scientist
have inﬂuence in the design of any sort of experi-
ment? Because. . . you know what I mean? It’s
hard enough for us to design an experiment so it
actually works and it makes sense, it’s hard
work, and you need to understand what you’re
doing. And, I cannot imagine that the general
public would have any sort of positive impact on
that. (Euan)
The biomedical scientists in particular were
also anxious about relinquishing any control
over the research process to non-scientists:
I guess, I’m also a bit scared of this idea of
handing over some of the power and control to
the public so they can inﬂuence how research is
conducted, because, I feel like the decisions
would be quite naive. It may not necessarily be
in the best interests of research progress or, you
know, getting a new drug or something like that.
(Tanya)
I respect other people’s opinions and they need
to respect mine. In terms of whether the experi-
ments are the right ones to do, then I think
that’s something you have to do within your peer
group. I think that’s not really. . . you’re not
going to get a better experiment design by talk-
ing to someone who doesn’t understand how to
do an experiment. (Peter)
The threat of losing control of the scientiﬁc
process to patients and the public loomed large
in the interviews with the laboratory based
biomedical scientists. For these participants
there was no ‘blurring’ of the distinction
between science and society. With a couple of
exceptions, health service researchers also
became uncomfortable when confronted with
the idea of sharing power and control with
patients and the public, highlighting the danger
of ‘devaluing research skills’, ‘mixing up roles’
and ‘representation’.
So I think for me, it’s absolutely ﬁne for patients
to have enormous power over the direction of
research and what the questions are, but the
technical sides of it are I don’t think appropriate
for patients. And then you get confused about
the sorts of patients you’re attracting, and what
actually is a lay person if they’re someone that’s
capable of carrying out a scientiﬁc study. . .So I
think it’s just a mixing up of roles that isn’t
terribly helpful to anyone. (Sam)
Attitudes to PES: ‘Getting people to understand
better what we do.’
Consistent with their attitudes to PPI, the bio-
medical scientists and some health services
researchers associated PES with a more tradi-
tional notion of public understanding of the
role of science in society. They talked about
their experiences of going into schools to
encourage young people to pursue careers in
science and attending science fairs to promote
public understanding of and trust in science.
They also discussed their experiences of science
communication, and in particular the diﬃcult
relationship they perceived between science and
the mass media.
I guess it’s the idea of ensuring that people
understand what it is that scientists do, and what
our research means, so that we’re not just. . .so
that academia doesn’t become something that’s
self-serving, or a game, but that people outside
of the academic world understand what that
means. (Jude)
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This conceptualization of PES was consistent
across the diﬀerent levels of experience within
the genetics and mental health themes. Some
participants felt scientists could do more in terms
of public engagement activities and this might be
a useful way of counteracting the negative por-
trayal of science in the mass media. Referring to
the debate about genetically modiﬁed foods,
Peter, a Reader in the Genetics theme, felt that
PES could make a contribution through ‘dispel-
ling improper views’. PES was a familiar concept
to the health service researchers in the innova-
tions theme, but they had more limited experi-
ence of engaging with the public in this way.
A Mode 2 perspective on PPI and PES: ‘We
weren’t informing them, they were informing us’
Only one participant talked passionately about
collaborating with the public and patients to
share power and control over the process of
knowledge production. She highlighted the need
to build engagement in the research process and
provide opportunities for service users (a term
she preferred to ‘patients’) to be involved in
shaping, critiquing and monitoring the research
process. She explained that she considered
engagement as involving agency, action and
will on the part of the participant. She linked
patient engagement to activism, whereby indi-
viduals trying to bring about change such as
those campaigning for medication for people
living with HIV/AIDS are proactive rather
than passive and organized to gain inﬂuence
through collective action. By contrast, she
observed what she described as ‘rhetorical,
tokenistic and box ticking’ approaches to PPI
in the UK:
I don’t think there is a lot of humility in the sci-
entiﬁc community about their own need to be
exposed, to. . ., because there is a certain elitism
that ﬂoats around these circles in which people
think they know the truth. . . So it’s not that
they’re dying to get input from others and widen
their perspectives. (Sue)
Sue and her colleague Jackie were also
critical of PES as tokenistic and alluded to
the deﬁcit model of public understanding of
science. Sue talked about her previous research
experience outside UK health services research.
Before coming to work as a health services
researcher, she had worked in an international
development context as both a researcher and
health promoter alongside activists seeking to
change policy and practice in sexual and repro-
ductive rights, including HIV. She felt that the
methods used in her previous research (mainly
qualitative methods) were particularly well sui-
ted to participation.
Sue’s perspective aligned with Wynne’s
description of a more democratic production of
knowledge where the roles of researchers and
the public are more ﬂuid. While only Sue associ-
ated herself with a more participatory research
tradition, other health service researchers shared
her view of the elitist research culture within
health care. Sam had observed a ‘natural resis-
tance’ to the idea of involving patients. Jackie,
another health services researcher agreed:
I think there is very much a normative ideal that
actually professionals are the only ones that
really have the authority and knowledge to write
research protocols and undertake it. (Jackie)
Jackie felt that it should be possible to give
the patient voice the same status as the profes-
sional voice in the research process. The
commitment to sharing authority with other
non-academic stakeholders and working in
partnership to produce knowledge expressed by
Sue is aligned with Mode 2 forms of knowl-
edge production. On the other hand, the need
to retain control over the research highlighted
by Jackie would ﬁt more closely with Mode 1
research where power, funding and agenda set-
ting remains within the Academy.
Discussion and conclusions
The participants in this study made a clear
distinction between PES (an activity that
aims to communicate research ﬁndings to the
public, engage the public with broader issues
of science policy or promote a greater under-
standing of the role of science in society) and
PPI (which they described as engagement
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with patient and carers in the conduct of
research projects and programmes). Despite
the PPI label, the public were not considered
as part of PPI activity. PES was widely
accepted but understood as the more tradi-
tional Public Understanding of Science; PPI
was resisted by the biomedical scientists but
accepted and sometimes embraced by health
services researchers. However, even in the lat-
ter cases there was a resistance to the idea of
power sharing. Mode 2 thinking in the pro-
duction of scientiﬁc knowledge, fusing both
PES and PPI, was exceptional and articulated
by only one participant in this study; an indi-
vidual with experience of activism and partic-
ipatory approaches to research.
The study revealed considerable variability
in activity and attitudes to PPI and PES
amongst diﬀerent types of researchers and
between individuals. There was a clear divide
between those who engaged in PPI and PES
and who felt that they gained positive beneﬁts
from engagement activities, and those who
were ‘going through the motions’ of engaging
the public in their research, whether it be
through PPI or PES activities. Most common
was a pragmatic description of ‘scripted’
engagement with the public, patients and carers
invited to ‘play the part’.
The health services researchers were more
likely to be actively engaged in PPI activities,
although the extent to which they thought this
was valuable activity varied between individu-
als. The biomedical scientists had less experi-
ence of PPI although funding concerns had
raised their awareness of the concept. Some
individuals had been inspired by positive expe-
riences of engaging with the public which led
to a shift in their attitudes and practice. With
the exception of two health services research-
ers, participants described a traditional model
of public understanding of science motivated
by the need to educate the public about science
and improve accountability.
Previous researchers have found it helpful to
use the concepts of Mode 1 and Mode 2
research to understand academic attitudes and
practice.11,17 While these studies have focused
on a range of aspects of academic practice
including agenda setting, interdisciplinary work-
ing, collaborations, outputs and dissemination,
less attention has been paid to the relationship
with the public and patients as key stakeholders
in research. Similarly, the original texts on
Mode 1 and Mode 23,10 make little mention of
the public, patients and service users. Our
analysis suggests that the diﬀerent types of
engagement activity undertaken with the public
and patients align with diﬀerent Modes. While
participants were broadly accepting of the
limited communication model associated with
Public Understanding of Science (an activity
more associated with Mode 1), they expressed
greater resistance to types of engagement with
the public and patients more associated with
Mode 2. While PPI guidance is increasingly
promoting Mode 2 knowledge production, the
underlying attitudes of many researchers
continue to reﬂect a Mode 1 set of values. For
example, many interview participants were clear
that only researchers can design and conduct
research (particularly biomedical research) and
that power and control by service users are
‘dirty words’. These ﬁndings support Ward
et al.’s14 conclusions that researchers are not
aiming for the higher rungs of Arnstein’s lad-
der18 with regard to PPI. Our analysis suggests
that it would be helpful to consider more active
forms of engagement with the public and
patients as part of the broader conceptualiza-
tion of Mode 2 knowledge production.
The notion of a ‘blurring of the divide’
between science and society was only evident
in one interview, where the researcher dis-
played a diﬀerent set of values to those of the
other participants in the study. As McKevitt19
observes, the production of knowledge is a
moral and political process, in which the expe-
riential knowledge of patients and the public
can be seen to constitute a threat. Wilsdon
et al.20 argue that the focus on the hardware of
engagement (the how to, methods, approaches,
guidelines etc.) rather than the ‘software’ of
values, norms and codes that shape scientiﬁc
practice helps to explain how the policy to
promote PPI has made little impact on the
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attitudes of academic researchers. The authors
highlight an aspirational vision captured in
Alan Irwin’s work21 on Citizen Science, in
which scientists (what Wildson et al. term
‘citizen scientists’) start to see their own con-
tribution to society as a key responsibility and
as part of their working lives. As Wilsdon
et al. prophesied in 2005:
We will end up with little more than the scientiﬁc
equivalent of corporate social responsibility: A
well-meaning, professionalized and busy ﬁeld,
propelled along by its own conferences and
reports, but never quite impinging on fundamen-
tal practices, assumptions and cultures.20
The data we report here provide further evi-
dence of the maintenance of Mode 1 academic
attitudes and values, despite the ‘changing
currents on the surface’.14 In our study, while
participant researchers were prepared to go
through the motions in pursuing PPI and PES
activities and listed the advantages of engage-
ment, the interviews revealed underlying
attitudes consistent with those reported in
previous studies14 and an active resistance to
sharing power and control in the process of
knowledge generation. Instead, the ‘defensive
power’ of the research community identiﬁed by
Whitley12 and ‘pull back’ to Mode 1 from
academic disciplines and institutions11 persist.
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